$GSK 3 SEC Filings

Filed On	Filing
30 Jan 2023	Form 3: Gsk Plc, 10% owner · Wave Life Sciences, Inc. Holds 10,683,761 shares of Ordinary Shares
14 Nov 2022	Form 3: Gsk Plc, 10% owner · Spero Therapeutics, Inc. Holds 9,190,606 shares of Common Stock
04 Nov 2022	Form 3: Gsk Plc, 10% owner · Chrome Holding Co.
06 Jul 2021	Form 3: Glaxosmithkline Plc, 10% owner · Cvrx, Inc
17 Jun 2021	Form 3: Glaxosmithkline Plc, 10% owner · Lyell Immunopharma, Inc.
11 Feb 2021	Form 3: Glaxosmithkline Plc, Director · Decibel Therapeutics, Inc.
16 Jul 2020	Form 3: Glaxosmithkline Plc, Director · Pandion Therapeutics, Inc.
09 Jul 2020	Form 3: Glaxosmithkline Plc, Director · Nkarta, Inc.
02 Jan 2020	Form 3: Glaxosmithkline Plc, Director · Orchard Therapeutics plc Holds 12,455,252 shares of Ordinary Shares, nominal value (GBP)0.10 per share
24 Oct 2019	Form 3: Glaxosmithkline Plc, 10% owner · Progyny, Inc. Holds 417,054 shares of Common Stock
17 Jul 2019	Form 3: Glaxosmithkline Plc, 10% owner · Fulcrum Therapeutics, Inc.
26 Jun 2019	Form 3: Glaxosmithkline Plc, Director · Morphic Holding, Inc.
23 May 2019	Form 3: Glaxosmithkline Plc, Director · Bicycle Therapeutics PLC
16 Apr 2019	Form 3: Glaxosmithkline Plc, Director · Turning Point Therapeutics, Inc.
25 Feb 2019	Form 3: Glaxosmithkline Plc, 10% owner · GENOCEA BIOSCIENCES, INC. Holds 12,069,937 shares of Common Shares
13 Sep 2018	Form 3: Glaxosmithkline Plc, 10% owner · Principia Biopharma Inc.
25 Jul 2018	Form 3: Glaxosmithkline Plc, 10% owner · Liquidia Technologies Inc
18 Jul 2018	Form 3: Glaxosmithkline Plc, 10% owner · CONSTELLATION PHARMACEUTICALS INC
27 Jun 2018	Form 3: Glaxosmithkline Plc, 10% owner · Translate Bio, Inc.
02 Nov 2017	Form 3: Glaxosmithkline Plc, 10% owner · Spero Therapeutics, Inc.

Comments